Biotricity, Inc. (BTCY)
OTCMKTS · Delayed Price · Currency is USD
0.2630
+0.0230 (9.58%)
Feb 13, 2026, 2:01 PM EST

Biotricity Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
15.4513.7912.069.647.653.38
Revenue Growth (YoY)
16.46%14.32%25.15%26.00%126.02%138.75%
Cost of Revenue
2.923.233.714.23.082.11
Gross Profit
12.5310.568.365.444.571.27
Selling, General & Admin
9.8910.8614.6117.6218.5611.93
Research & Development
2.52.162.573.232.742.06
Operating Expenses
12.3913.0117.1820.8521.3113.98
Operating Income
0.14-2.45-8.83-15.41-16.74-12.71
Interest Expense
-4.12-5.2-5.19-2.58-6.08-2.79
Other Non Operating Income (Expenses)
-0.07-0.38-0.03-0.59-0.670.45
EBT Excluding Unusual Items
-4.05-8.03-14.05-18.59-23.49-15.05
Other Unusual Items
0.03-0.39-0.04-0.07-5.64-0.44
Pretax Income
-4.02-8.42-14.09-18.66-29.13-15.49
Net Income
-4.02-8.42-14.09-18.66-29.13-15.49
Preferred Dividends & Other Adjustments
0.683.520.830.881.090.96
Net Income to Common
-4.7-11.94-14.93-19.53-30.22-16.45
Shares Outstanding (Basic)
27229986
Shares Outstanding (Diluted)
27229986
Shares Change (YoY)
54.65%139.38%3.83%14.32%21.13%4.36%
EPS (Basic)
-0.18-0.55-1.66-2.26-3.99-2.63
EPS (Diluted)
-0.18-0.56-1.66-2.26-3.99-2.63
Free Cash Flow
-1.1-2.38-6.69-13.55-15.19-11.08
Free Cash Flow Per Share
-0.04-0.11-0.74-1.56-2.01-1.77
Gross Margin
81.09%76.61%69.27%56.46%59.74%37.60%
Operating Margin
0.91%-17.76%-73.18%-159.87%-218.77%-375.56%
Profit Margin
-30.40%-86.60%-123.75%-202.65%-395.01%-486.10%
Free Cash Flow Margin
-7.11%-17.26%-55.49%-140.55%-198.60%-327.37%
EBITDA
0.15-2.44-8.82-15.4-16.73-
EBITDA Margin
0.95%-17.71%-73.13%-159.81%-218.74%-
D&A For EBITDA
0.010.010.010.010-
EBIT
0.14-2.45-8.83-15.41-16.74-12.71
EBIT Margin
0.91%-17.76%-73.18%-159.87%-218.77%-
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.